Viewing Study NCT05571969


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2025-12-25 @ 8:43 PM
Study NCT ID: NCT05571969
Status: SUSPENDED
Last Update Posted: 2025-05-07
First Post: 2022-10-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Sponsor: Allarity Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module